Half-year report · Q2
3939.TEDINET S100VQ7Q
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.7bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥5.0bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥765m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥669m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥764m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥675m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥764m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥684m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥518m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥920m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥518m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥6.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥6.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥5.6bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.1bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.3bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥4.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.4bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥551m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥438m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥539m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥344m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥194m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥486m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥614m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥434m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥10.93 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.38 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.65 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 65.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥18m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥74m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥551m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥551m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥57m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥1.8bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥1.8bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥5m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥737m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥344m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥330m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥14m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥18m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥839m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥21m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥15m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥641m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥285m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥281m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥4m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥690m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 536
| Item | Context | Value | Unit |
|---|---|---|---|
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | Prior1YTDDuration | -5897000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | CurrentYTDDuration | － | JPY |
| Decrease increase in accounts receivable trade and contract assets ope cf | Prior1YTDDuration | -129944000 | JPY |
| Decrease increase in accounts receivable trade and contract assets ope cf | CurrentYTDDuration | 8652000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | 409000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | 6031000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 63705000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -56589000 | JPY |
| Increase decrease in contract liabilities ope cf | Prior1YTDDuration | -133743000 | JPY |
| Increase decrease in contract liabilities ope cf | CurrentYTDDuration | -82166000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | 1139000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -4712000 | JPY |
| Other net ope cf | Prior1YTDDuration | -20974000 | JPY |
| Other net ope cf | CurrentYTDDuration | -49487000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 633801000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 793298000 | JPY |
| Interest income received ope cf | Prior1YTDDuration | 122000 | JPY |
| Interest income received ope cf | CurrentYTDDuration | 1492000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -3240000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -2980000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -195470000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -240313000 | JPY |
| Income taxes refund ope cf | Prior1YTDDuration | 3268000 | JPY |
| Income taxes refund ope cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 438481000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 551497000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -119060000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -67703000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 4202000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | － | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -102509000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -103757000 | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1YTDDuration | － | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYTDDuration | -27845000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | Prior1YTDDuration | 1590000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYTDDuration | 15611000 | JPY |
| Proceeds from sales of stocks of subsidiaries and affiliates inv cf | Prior1YTDDuration | 9637000 | JPY |
| Proceeds from sales of stocks of subsidiaries and affiliates inv cf | CurrentYTDDuration | － | JPY |
| Collection of long term loans receivable inv cf | Prior1YTDDuration | 625000 | JPY |
| Collection of long term loans receivable inv cf | CurrentYTDDuration | 750000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | -355141000 | JPY |
| Purchase of insurance funds inv cf | Prior1YTDDuration | -916000 | JPY |
| Purchase of insurance funds inv cf | CurrentYTDDuration | -736000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | Prior1YTDDuration | 12116000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -194314000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -538822000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 60000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |